Physician

Priyanka Pathak, M.D.

According to 2025 Medicare claims, Priyanka Pathak, M.D. (NPI: 1417189440) practices hematology/oncology in the Athens-Clarke County, GA market, with the plurality of this provider's patient population coming from Clarke, GA. This provider's primary affiliated billing organization is UNIVERSITY CANCER & BLOOD CENTER LLC (NPI: 1346343761; TIN: 20-1842623) and primary practice location at 30607-1465. Pathak is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Pathak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 376 traditional Medicare patients, billed 36,441 HCPCS/CPT codes, and received $975,525 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 241 prescription claims across 60 beneficiaries totaling $149,605 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 32 claims. Open Payments data shows 88 records totaling $2,140. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $9,666 and ending at $975,525. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $132,559 and ending at $149,605. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	74	129	$9,666
2016	315	732	$46,692
2017	289	721	$45,975
2018	245	574	$35,550
2019	282	774	$51,003
2020	254	600	$42,026
2021	261	595	$46,840
2022	210	369	$28,917
2023	173	1,756	$54,713
2024	376	36,441	$975,525

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	67	$132,559
2016	115	846	$1,813,415
2017	136	898	$2,608,443
2018	106	633	$1,723,524
2019	103	603	$1,827,670
2020	123	663	$2,953,991
2021	125	745	$3,531,256
2022	149	1,024	$4,796,842
2023	105	648	$2,645,024
2024	60	241	$149,605

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	32	$985
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	194	282	$91
96372	Injection of drug or substance under skin or into muscle	72	137	$10
36415	Insertion of needle into vein for collection of blood sample	137	260	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	129	250	$8
83615	Lactate dehydrogenase (enzyme) level	61	117	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	21	808	$15,942
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	229	$184
Acyclovir	Acyclovir	12	412	$103
Anastrozole	Anastrozole	13	390	$66
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	373	$23

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	88	$2,140	Celgene Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Priyanka Pathak, M.D.?

Tedicare shows public-source Medicare data for Priyanka Pathak, M.D. (NPI 1417189440), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Priyanka Pathak, M.D. have ACO affiliation data?

Priyanka Pathak, M.D. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Priyanka Pathak, M.D.?

Priyanka Pathak, M.D. is linked to UNIVERSITY CANCER & BLOOD CENTER LLC (billing NPI 1346343761) in the available physician profile data.

Does Priyanka Pathak, M.D. have Open Payments data?

Priyanka Pathak, M.D. has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.